SBC / revenue moved 2030 bp lower
SBC / revenue changed -2030 basis points from the comparable as-filed period.
36.17%→15.87%3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →FHTX financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Research & development decreased 15.0%
Research & development changed -15.0% from the comparable as-filed period.
$21.8M→$18.5M3 prior comparisons
Working capital / assets moved 302 bp higher
Working capital / assets changed +302 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
55.72%→58.74%4 prior comparisons
Free-cash-flow margin moved 16684 bp higher
Free-cash-flow margin changed +16684 basis points from the comparable as-filed period.
-278.18%→-111.34%3 prior comparisons
Operating cash-flow margin moved 16686 bp higher
Operating cash-flow margin changed +16686 basis points from the comparable as-filed period.
-277.89%→-111.03%3 prior comparisons
R&D / revenue moved 17312 bp lower
R&D / revenue changed -17312 basis points from the comparable as-filed period.
288.37%→115.25%3 prior comparisons
Total assets decreased 10.1%
Total assets changed -10.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$226.2M→$203.4M4 prior comparisons
Working capital decreased 5.2%
Working capital changed -5.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$126.1M→$119.5M4 prior comparisons
Shares outstanding increased 5.1%
Shares outstanding changed +5.1% from the comparable as-filed period. The change ranks at the 50th percentile of 8 prior comparable changes.
56,529,969→59,385,3158 prior comparisons
Cash & equivalents decreased 6.2%
Cash & equivalents changed -6.2% from the comparable as-filed period.
$72.6M→$68.1M3 prior comparisons
Stock-based compensation decreased 6.7%
Stock-based compensation changed -6.7% from the comparable as-filed period.
$2.7M→$2.6M3 prior comparisons
Capex / revenue moved 2 bp higher
Capex / revenue changed +2 basis points from the comparable as-filed period.
0.29%→0.31%3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.